|
Senate Bill 1367 |
Senate Author: Menéndez et al. |
|
Effective: 9-1-17 |
House Sponsor: Howard et al. |
Senate Bill 1367 amends the Education Code to authorize each public institution of higher education to adopt and implement a policy regarding the maintenance, storage, administration, and disposal of epinephrine auto-injectors on the institution's campus. The bill requires such a policy to provide that authorized and trained personnel or volunteers may administer an epinephrine auto-injector to a person who is reasonably believed to be experiencing anaphylaxis on the institution's campus and authorizes the policy to extend that provision to include administration to a person at or in transit to an off-campus event. The bill sets out requirements for the campus policy and provides for the prescription by a physician and dispensing by a pharmacist of epinephrine auto-injectors in the name of the institution on a non-patient-specific basis. The bill provides for the immunity from civil or criminal liability or disciplinary action of a person, and the immunity from suit of an institution or an institution's campus, for an action or failure to act under the bill's epinephrine auto-injector policy provisions.
Senate Bill 1367 expands the duties of the advisory committee established to examine and review the administration of epinephrine auto-injectors on public school district and open enrollment charter school campuses to include examining and reviewing the administration of epinephrine auto-injectors on an institution of higher education campus. The bill adds to the committee's required membership at least one employee of a general academic teaching institution and at least one employee of a public junior college or a public technical institute.